Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

BACKGROUND: Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new rifampicin-sparing regimens. However, little information about the extent of resistance to these drugs at the population level is available. METHODS: In a molecular epidemiology analysis, we used population-bas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Infect Dis
Main Authors: Zignol, Matteo, Dean, Anna S, Alikhanova, Natavan, Andres, Sönke, Cabibbe, Andrea Maurizio, Cirillo, Daniela Maria, Dadu, Andrei, Dreyer, Andries, Driesen, Michèle, Gilpin, Christopher, Hasan, Rumina, Hasan, Zahra, Hoffner, Sven, Husain, Ashaque, Hussain, Alamdar, Ismail, Nazir, Kamal, Mostofa, Mansjö, Mikael, Mvusi, Lindiwe, Niemann, Stefan, Omar, Shaheed V, Qadeer, Ejaz, Rigouts, Leen, Ruesch-Gerdes, Sabine, Schito, Marco, Seyfaddinova, Mehriban, Skrahina, Alena, Tahseen, Sabira, Wells, William A, Mukadi, Ya Diul, Kimerling, Michael, Floyd, Katherine, Weyer, Karin, Raviglione, Mario C
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science ;, The Lancet Pub. Group 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030278/
https://ncbi.nlm.nih.gov/pubmed/27397590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(16)30190-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados